Thank you for your interest in clinical trials for Eriline and the surrounding suburbs. Please view all available clinical trials in Eriline below. If you receive too many clinical trial listings you may enter keywords and/or reduce search distance.
Your search returned no results. Get alerts when studies become available.
Your search returned 21 studies. (Get alerts for new studies):Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress SyndromeConditions: Sepsis - Acute Lung Injury - Acute Respiratory Distress SyndromeLocation: Hazard, Kentucky Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With GemcitabineConditions: Pancreatic Cancer - Ductal Adrenocarcinoma - Exocrine Pancreatic CancerLocation: Hazard, Kentucky PAVES: Pegfilgrastim Anti-VEGF Evaluation StudyConditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal CancerLocation: Hazard, Kentucky Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%Conditions: RosaceaLocation: Corbin, Kentucky Chronic Plaque Psoriasis (Ps) RegistryConditions: Chronic Plaque PsoriasisLocation: Corbin, Kentucky A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic DermatitisConditions: Atopic DermatitisLocation: Corbin, Kentucky Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone CancerConditions: Breast CancerLocation: Hazard, Kentucky Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular LymphomaConditions: Follicular LymphomaLocation: Hazard, Kentucky Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismConditions: Venous ThrombosisLocation: Hazard, Kentucky Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary EmbolismConditions: Venous ThrombosisLocation: Hazard, Kentucky Study of Immunotherapy to Treat Advanced Prostate CancerConditions: Prostate CancerLocation: Hazard, Kentucky Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and CarboplaConditions: Lung Cancer - Non Small CellLocation: Hazard, Kentucky Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple MyelomaConditions: Multiple MyelomaLocation: Hazard, Kentucky An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid RConditions: Reversal of CoagulopathyLocation: Hazard, Kentucky A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the LungConditions: Adenocarcinoma of the LungLocation: Hazard, Kentucky Combining Lesinurad With Allopurinol in Inadequate RespondersConditions: GoutLocation: Elizabethtown, Kentucky Efficacy and Safety of NVC-422 in the Treatment of Adenoviral ConjunctivitisConditions: Adenoviral ConjunctivitisLocation: Hazard, Kentucky Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung CancerConditions: Non Small Cell Lung CancerLocation: Louisville, Kentucky Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyConditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung CancerLocation: Hazard, Kentucky Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative BreasConditions: Breast CancerLocation: Hazard, Kentucky ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung CancerConditions: Non-Small Cell Lung Cancer (NSCLC)Location: Hazard, Kentucky
Didn't find what you were looking for? Try these alternatives: